What are the challenges of conducting cannabinoid research in populations with limited access to healthcare?
What are the challenges of conducting cannabinoid research in populations with limited access to healthcare? Conducting cannabinoid research in populations with limited access to healthcare presents challenges such as recruiting participants, ensuring informed consent, and maintaining ethical standards. Limited healthcare access can lead to underrepresentation of marginalized populations in clinical trials, resulting in a lack of generalizable findings. Additionally, researchers may face barriers in providing adequate education about cannabinoid therapies to participants unfamiliar with these treatments. Socioeconomic factors can also impact participants' ability to adhere to study protocols or follow-up appointments. Addressing these challenges requires collaborative efforts between researchers, community organizations, and policymakers to improve healthcare access and promote equitable research practices (Hurd et al., 2021).